title: A preliminary study on the significant value of beta-2-microglobulin over serum creatinine in renal transplant rejection and renal failure.
abstract: BACKGROUND
  Beta-2-microglobulin (beta2M) is a light chain of HLA class I molecule, which is filtered by glomerulus, reabsorbed and catabolised by proximal tubule. It is one of the markers of transplant rejection. The aim of the present study was to find out the level of beta2M in acute renal failure (ARF), chronic renal failure (CRF), renal transplant rejection (TR) and renal transplantation stable (TS) cases, and correlation of beta2M with serum creatinine (SCr) in assessing renal failure.
  
  
  METHODS
  23 patients with ARF, 22 patients with CRF, six cases of TR, seven patients with TS, and 28 normal healthy controls were studied within a one-year period.
  
  
  RESULTS
  Highest mean value of beta2M was noted (12.97 +/- 3.83 microg/ml) in CRF, and all cases had elevated beta2M of which 81.8 percent of cases had beta2M above 10 microg/ml. In ARF, all cases had elevated beta2M and 78.3 percent patients had a value more than 10 microg/ml with a mean value of 11.75 +/- 2.09 microg/ml. TR cases also had elevated beta2M but 50 percent had mild elevation (less than 10 microg/ml) and 50 percent had marked elevation (more than 10 microg/ml). 42.8 percent of TS patients also had mild elevation of beta2M in the range 2.10-3.70 microg/ml. Interestingly, in normal healthy controls, 21.4 percent of patients had mild elevation of beta2M of 2.1-2.75 microg/ml, while 78.6 percent of cases had a normal range of beta2M (less than 2 microg/ml). All normal healthy controls and 71.4 percent of TS cases had normal SCr (less than 1.4 mg/dL). All cases of CRF and TR cases, and 28.6 percent of TS cases had elevated SCr. 81.8 percent of cases with CRF and 60.9 percent of cases with ARF had a marked rise of serum creatinine above 5 mg/dL.
  
  
  CONCLUSIONS
  Our study showed that beta2M is not superior over SCr for renal failure and TR cases, because it is also elevated in 21.4 percent of normal controls and 42.8 percent of TS cases. SCr is a cheaper, simpler and comparatively good test to assess renal failure and TR.
authors.affiliation: Division of Immunopathology, Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.
authors.forename: G K
authors.initials: GK
authors.lastname: Sonkar
authors.lastname: Usha
authors.forename: R G
authors.initials: RG
authors.lastname: Singh
mesh_terms: D058186:Acute Kidney Injury / Q000097:blood* / Q000652:urine; D016022:Case-Control Studies; D003404:Creatinine / Q000097:blood*; D006084:Graft Rejection / Q000097:blood* / Q000652:urine; D006801:Humans; D016030:Kidney Transplantation / Q000379:methods*; D007684:Kidney Tubules / Q000378:metabolism; D016031:Liver Transplantation / Q000009:adverse effects* / Q000379:methods; D011183:Postoperative Complications / Q000175:diagnosis; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D016896:Treatment Outcome; D001613:beta 2-Microglobulin / Q000097:blood* / Q000652:urine*
chemical_list: D001613:beta 2-Microglobulin; D003404:Creatinine